Abstract
The purpose of this study was to assess the apoptotic -related gene expression of single-agent oxaliplatin in vitro. Growth inhibition studies were performed using the human cerebral cavernous malformation-1 colorectal adenocarcinoma cell line and mucosa-associated lymphoid tissue-nt-1 lymphoma cell line. At 50% inhibitory concentrations, oxaliplatin displayed suppressive effects toward Bcl-2 and the surviving expression in human cancer cell lines, whereas the expression of Fas/FasL was completely abolished in peripheral blood cells. Our data showed that oxaliplatin exerts potent antiapoptotic effects in human normal peripheral blood mononuclear cells at the suprapharmacologic concentration, warranting further investigations in the role of autoimmune adverse events while being used in numerous cycles for the treatment of malignancies.
Original language | English |
---|---|
Pages (from-to) | 41-42 |
Number of pages | 2 |
Journal | Genomic Medicine, Biomarkers, and Health Sciences |
Volume | 4 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 2012 Mar |
All Science Journal Classification (ASJC) codes
- Biomedical Engineering
- General Biochemistry,Genetics and Molecular Biology
- Drug Discovery